Please Wait
Applying Filters...
menu
    • menu
    FDA okays 50 new drugs in 2024; BMS’ Cobenfy, Lilly’s Kisunla lead pack of breakthrough therapies

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2025: J&J’s US$ 14.6 bn Intra-Cellular buyout kicks off deal frenzy; Ozempic clinches FDA nod for CKD

    Stock Recap
    #PipelineProspector

    Menu

    Locetar

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,450Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/01/2025 Inabata France S.A.S
    France
    		 PHARMASYNTHESE Saint Pierre Les Elbeuf FR CEP 2016-312 - Rev 01 Amorolfine hydrochloride 2024-10-29 Valid Chemical 2756
    28/01/2025 Olon S.p.A
    Italy
    		 OLON S.P.A. Rodano IT CEP 2016-071 - Rev 01 Amorolfine hydrochloride 2024-09-11 Valid Chemical 2756